Skip to content

Gynecological Pelvic Floor Muscle Training

The Efficacy of Pelvic Floor Muscle Training in Gynecological Cancer Survivors: A Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01811602
Enrollment
40
Registered
2013-03-14
Start date
2013-12-31
Completion date
2016-08-31
Last updated
2015-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence

Keywords

Training, Physiotherapy, Pelvic floor muscles

Brief summary

A randomized controlled trial pilot study to test the efficacy of a pelvic muscular training intervention led by a physiotherapist on urinary incontinence, quality of life and sexual health in women who report urinary urgency and incontinence following surgery and radiation treatment for gynecological cancer vs. usual care (a 1-page sheet on Kegel exercises).

Interventions

OTHERTraining

The participants randomized to the pelvic floor muscle training intervention will receive pelvic floor muscle training (0-12 weeks) delivered by a physiotherapist with clinical expertise and training in treating pelvic floor dysfunction. The intervention is 9 individual, one-on-one, 45-minute sessions; weekly for weeks 0-6 and bi-weekly for weeks 7-12 (first session will be 60 minutes). The sessions will provide pelvic floor muscle training based on the latest evidence, including biofeedback, to teach the correct technique for pelvic floor contractions, and participants will be asked to complete daily pelvic floor exercises at home.

OTHERUsual Care

The participants randomized to the educational pamphlet intervention (usual care control) will receive a 1-page sheet on pelvic floor muscle training, specifically Kegel exercises, which is equivalent to current standard care. Individuals randomized to this group will be placed on the clinic waiting list and be eligible for treatment following completion of the 12 week (end of study) measures.

Sponsors

British Columbia Cancer Agency
CollaboratorOTHER
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- treated with surgery and adjuvant treatment, including radiation, for gynecological cancer within the last 3 years

Exclusion criteria

* stage IV cancer or stage III and IV cervical cancer * radiation not part of treatment * known spinal or long bone metastases diagnosis with a neuromuscular disorder that may impact pelvic floor muscle function * urinary incontinence issues prior to cancer diagnosis * scheduled or previous surgical treatment of incontinence * fecal incontinence * body mass index (BMI) \> 35 * use of medications to improve bladder function * unable to complete questionnaires in English or unable to actively participate in physiotherapy treatment provided in English.

Design outcomes

Primary

MeasureTime frameDescription
Urinary incontinence12 weeksUrinary incontinence, measured using the International Consultation on Incontinence Questionnaire Urinary Incontinence (ICIQ-UI Short Form) and bladder diary

Countries

Canada

Contacts

Primary ContactKristin Campbell, PhD
kristin.campbell@ubc.ca604-827-4704
Backup ContactSarah Finlayson
Sarah.Finlayson@vch.ca604-877-6000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026